News Release Biotricity strengthens its foundation for growth, achieves lower cost of sales, expanding margins of 73% and increased device sales, for third quarter of Fiscal Year 2024 Topline growth with better quality revenue mix Increase in subscription revenue (fixed) vs usage based…biotricityFebruary 21, 2024
News Release Biotricity to host third quarter Fiscal Year 2024 financial results and business update call on February 21st REDWOOD CITY, Calif., Feb 19, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…audavantFebruary 19, 2024
News Release Biotricity advances towards breakeven milestone – set to announce record margins and operational efficiency for third quarter of Fiscal Year 2024 Company continues its shift to subscription-based revenue, prioritizing margin improvement and operational efficiency enhancements, on…audavantFebruary 14, 2024
News Release Biotricity expands development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats Company's growing data ecosystem supports the development of large data models for its future predictive…audavantJanuary 23, 2024
News Release Biotricity delivers record margins and double digit year-over-year sales growth for second quarter of fiscal year 2024 Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward…audavantNovember 14, 2023
News Release Biotricity to host second quarter fiscal year 2024 financial results and business update call on November 14th Biotricity improves margins while lowering selling expenses and operating losses REDWOOD CITY, Calif., Nov 10,…audavantNovember 10, 2023
News Release Biotricity releases another groundbreaking product: Biotres Pro Company further expands its current product portfolio, making it the most comprehensive Remote Patient and…audavantOctober 31, 2023
News Release Biotricity continues to expand patent portfolio with latest patent filing for Bioheart device REDWOOD CITY, Calif., Oct 10, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a Technology-as-a-Service (TaaS) company…audavantOctober 10, 2023
News Release CORRECTION BY SOURCE: Biotricity announces patent filing for cutting-edge Biotres device REDWOOD CITY, Calif., Oct 04, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) a Technology-as-a-Service (TaaS) company…audavantOctober 4, 2023
News Release Biotricity announces patient filing for cutting-edge Biotres device REDWOOD CITY, Calif., Oct 03, 2023 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company…audavantOctober 3, 2023